Breast cancer, metastatic
Invited Discussant 241PD, 242PD and 243PD
Date
10 Sep 2017Session
Breast cancer, metastaticPresenters
Maria Vittoria DieciAuthors
M.V. DieciAuthor affiliations
- Department Of Surgery, Oncology And Gastroenterology, University of Padova, 35128 - Padova/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
2434 - OlympiAD: Further efficacy outcomes in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician’s choice
Presenter: Suzette Delaloge
Session: Breast cancer, metastatic
Resources:
Abstract
941 - A randomized, double-blind study of PF-05280014 (a potential trastuzumab biosimilar) vs trastuzumab, both in combination with paclitaxel, as first-line treatment for HER2-positive metastatic breast cancer
Presenter: Mark Pegram
Session: Breast cancer, metastatic
Resources:
Abstract
3996 - Everolimus (EVE) + letrozole (LET) in patients (pts) with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): progression-free survival (PFS) subgroup analyses in BOLERO-4
Presenter: Thomas Bachelot
Session: Breast cancer, metastatic
Resources:
Abstract
1498 - Duration of response and tumor shrinkage with first-line ribociclib + letrozole in postmenopausal women with HR+, HER2– ABC
Presenter: Wolfgang Janni
Session: Breast cancer, metastatic
Resources:
Abstract
1833 - Efficacy of two times four versus continuous eight cycles of paclitaxel/bevacizumab as first-line chemotherapy in metastatic breast cancer: the Stop&Go study of the Dutch Breast Cancer Research Group (BOOG)
Presenter: Anouk Claessens
Session: Breast cancer, metastatic
Resources:
Abstract
Breast cancer, metastatic: Invited Discussant LBA12, 240PD and LBA15
Presenter: Aleix Prat
Session: Breast cancer, metastatic
Resources:
Slides
Webcast
Breast cancer, metastatic: Invited Discussant 244PD, 245PD and 246PD
Presenter: Alessandra Gennari
Session: Breast cancer, metastatic
Resources:
Slides
Webcast
4625 - Genomic analyses reveal potential recurrence markers of locally advanced triple negative breast cancer treated by combined neoadjuvant EGFR targeting and chemotherapy
Presenter: Nina Radosevic-Robin
Session: Breast cancer, metastatic
Resources:
Abstract
2194 - SToRM: a clinical cohort to identify genetic variability related to metastatic phenotypes
Presenter: David Cox
Session: Breast cancer, metastatic
Resources:
Abstract